FDA Brief

Company record

Devalingam Mahalingam, M.D., Ph.D.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Devalingam Mahalingam, M.D., Ph.D..

Warning letters

  1. Devalingam Mahalingam, M.D., Ph.D.

    FDA warns clinical investigator Devalingam Mahalingam, M.D., Ph.D. over a 100-fold investigational drug overdose that led to a subject's death.

    High risk